Arvinas Inc. (ARVN)
NASDAQ: ARVN
· Real-Time Price · USD
7.29
0.60 (8.97%)
At close: May 28, 2025, 3:59 PM
7.22
-1.03%
Pre-market: May 29, 2025, 04:22 AM EDT
8.97% (1D)
| Bid | 7.18 |
| Market Cap | 532.47M |
| Revenue (ttm) | 426.9M |
| Net Income (ttm) | -46.6M |
| EPS (ttm) | -0.66 |
| PE Ratio (ttm) | -11.05 |
| Forward PE | -2.04 |
| Analyst | Buy |
| Ask | 7.69 |
| Volume | 3,571,002 |
| Avg. Volume (20D) | 3,026,565 |
| Open | 6.70 |
| Previous Close | 6.69 |
| Day's Range | 6.75 - 7.50 |
| 52-Week Range | 5.90 - 35.34 |
| Beta | 2.23 |
About ARVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ARVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
-24.84%
Arvinas shares are trading lower. The company repo...
Unlock content with
Pro Subscription
2 months ago
-52.73%
Arvinas shares are trading lower after the company announced topline results from the phase 3 VERITAC-2 Trial of Vepdegestrant Monotherapy Versus Fulvestrant in adults with advanced or retastatic breast cancer.
2 weeks ago · accessnewswire.com
ARVN ACTIVE INVESTIGATION: Lost Money on Arvinas, Inc.? Contact Levi & Korsinsky NowNEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Arvinas, Inc. ("Arvinas") (NASDAQ:ARVN) concerning possible violations of ...
